Our findings contribute to the expanding phenotypic spectrum of CASPR2 and LGI1 autoimmune syndromes, suggesting that these 2 antigens, particularly CASPR2, may potentially serve as novel target antigens and be implicated in the etiology of Isaac syndrome. The gene discussed is LGI1; the disease is Isaacs syndrome.